{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:00:27Z","timestamp":1790906427395,"version":"4.1.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,7,29]]},"DOI":"10.7759\/cureus.16731","type":"journal-article","created":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T17:39:48Z","timestamp":1627580388000},"source":"Crossref","is-referenced-by-count":2,"title":["Neuroblastoma: A Case of Massive Hepatomegaly"],"prefix":"10.7759","author":[{"given":"Qamar","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Ibraiz","family":"Bilal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fawwad A","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Umer Riaz","family":"Gondal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan","family":"Arif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1148\/rg.2018170132","article-title":"Updates in diagnosis, management, and treatment of neuroblastoma","volume":"38","author":"Swift CC","year":"2018","unstructured":"Swift CC, Eklund MJ, Kraveka JM, Alazraki AL. Updates in diagnosis, management, and treatment of neuroblastoma. Radiographics. 2018, 38:566-80. 10.1148\/rg.2018170132","journal-title":"Radiographics"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yapd.2011.03.011","article-title":"Neuroblastoma","volume":"58","author":"Colon NC","year":"2011","unstructured":"Colon NC, Chung DH. Neuroblastoma. Adv Pediatr. 2011, 58:297-311. 10.1016\/j.yapd.2011.03.011","journal-title":"Adv Pediatr"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyx176","article-title":"Neuroblastoma","volume":"48","author":"Nakagawara A","year":"2018","unstructured":"Nakagawara A, Li Y, Izumi H, Muramori K, Inada H, Nishi M. Neuroblastoma. Jpn J Clin Oncol. 2018, 48:214-41. 10.1093\/jjco\/hyx176","journal-title":"Jpn J Clin Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s12098-017-2298-0","article-title":"Management of neuroblastoma: ICMR consensus document","volume":"84","author":"Bansal D","year":"2017","unstructured":"Bansal D, Totadri S, Chinnaswamy G, et al.. Management of neuroblastoma: ICMR consensus document. Indian J Pediatr. 2017, 84:446-55. 10.1007\/s12098-017-2298-0","journal-title":"Indian J Pediatr"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2020.102924","article-title":"Role and toxicity of radiation therapy in neuroblastoma patients: a literature review","volume":"149","author":"Zhao Q","year":"2020","unstructured":"Zhao Q, Liu Y, Zhang Y, et al.. Role and toxicity of radiation therapy in neuroblastoma patients: a literature review. Crit Rev Oncol Hematol. 2020, 149:102924. 10.1016\/j.critrevonc.2020.102924","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3468(95)90576-6","article-title":"Surgical management and outcome of locoregional neuroblastoma: comparison of the Childrens Cancer Group and the International Staging Systems","volume":"30","author":"Haase GM","year":"1995","unstructured":"Haase GM, Atkinson JB, Stram DO, Lukens JN, Matthay KK. Surgical management and outcome of locoregional neuroblastoma: comparison of the Childrens Cancer Group and the International Staging Systems. J Pediatr Surg. 1995, 30:289-295.  10.1016\/0022-3468(95)90576-6","journal-title":"J Pediatr Surg"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.05.571","article-title":"Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology Group","volume":"23","author":"London WB","year":"2005","unstructured":"London WB, Castleberry RP, Matthay KK, et al.. Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology Group. J Clin Oncol. 2005, 23:6459-65. 10.1200\/JCO.2005.05.571","journal-title":"J Clin Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1993.11.8.1466","article-title":"Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment","volume":"11","author":"Brodeur GM","year":"1993","unstructured":"Brodeur GM, Pritchard J, Berthold F, et al.. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol. 1993, 11:1466-77. 10.1200\/JCO.1993.11.8.1466","journal-title":"J Clin Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.6.2007","article-title":"Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: the pediatric oncology group experience--a pediatric oncology group study","volume":"16","author":"Katzenstein HM","year":"1998","unstructured":"Katzenstein HM, Bowman LC, Brodeur GM, et al.. Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: the pediatric oncology group experience--a pediatric oncology group study. J Clin Oncol. 1998, 16:2007-17. 10.1200\/JCO.1998.16.6.2007","journal-title":"J Clin Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(87)90312-9","article-title":"Results of therapy in stage IV-S neuroblastoma with massive hepatomegaly","volume":"13","author":"Blatt J","year":"1987","unstructured":"Blatt J, Deutsch M, Wollman MR. Results of therapy in stage IV-S neuroblastoma with massive hepatomegaly. Int J Radiat Oncol Biol Phys. 1987, 13:1467-1471. 10.1016\/0360-3016(87)90312-9","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.23186","article-title":"A sequential treatment algorithm for infants with stage 4s neuroblastoma and massive hepatomegaly","volume":"59","author":"Weintraub M","year":"2012","unstructured":"Weintraub M, Waldman E, Koplewitz B, Bloom AI, Gross E, Freeman AI, Revel-Vilk S. A sequential treatment algorithm for infants with stage 4s neuroblastoma and massive hepatomegaly. Pediatr Blood Cancer. 2012, 59:182-4. 10.1002\/pbc.23186","journal-title":"Pediatr Blood Cancer"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.00419","article-title":"Defining risk factors for chemotherapeutic intervention in infants with stage 4S neuroblastoma: A report from Children\u2019s Oncology Group Study ANBL0531","volume":"37","author":"Twist CJ","year":"2019","unstructured":"Twist CJ, Naranjo A, Schmidt ML, et al.. Defining risk factors for chemotherapeutic intervention in infants with stage 4S neuroblastoma: A report from Children\u2019s Oncology Group Study ANBL0531. J Clin Oncol. 2019, 37:115-24. 10.1200\/JCO.18.00419","journal-title":"J Clin Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/65460-neuroblastoma-a-case-of-massive-hepatomegaly","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:27:43Z","timestamp":1707506863000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/65460-neuroblastoma-a-case-of-massive-hepatomegaly"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,29]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.16731","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7,29]]}}}